Skip to content
Publicly Available Published by De Gruyter August 1, 2017

Hair testing of GHB: an everlasting issue in forensic toxicology

Francesco Paolo Busardò, Simona Pichini, Simona Zaami, Roberta Pacifici and Pascal Kintz



In this paper, the authors present a critical review of different studies regarding hair testing of endogenous γ-hydroxybutyrate (GHB), concentrations in chronic users, and values measured after a single GHB exposure in drug facilitated sexual assault (DFSA) cases together with the role of a recently identified GHB metabolite, GHB-glucuronide.


The following databases (up to March 2017) PubMed, Scopus and Web of Science were used, searching the following key words: γ-hydroxybutyrate, GHB, GHB glucuronide, hair. The main key words “GHB” and “γ-hydroxybutyrate” were searched singularly and then associated individually to each of the other keywords.


Of the 2304 sources found, only 20 were considered appropriate for the purpose of this paper. Summing up all the studies investigating endogenous GHB concentration in hair, a very broad concentration range from 0 to 12 ng/mg was found. In order to detect a single GHB dose in hair it is necessary to commonly wait 1 month for collecting hair and a segmental analysis of 3 or 5 mm fragments and the calculation of a ratio between the targeted segment and the others represent a reliable method to detect a single GHB intake considering that the ratios presently proposed vary from 3 and 10. The only two studies so far performed, investigating GHB-Glucuronide in hair, show that the latter does not seem to provide any diagnostic information regarding GHB exposure.


A practical operative protocol is proposed to be applied in all suspected cases of GHB-facilitated sexual assault (GHB-FSA).


The use of hair as an alternative and/or complementary matrix has increased in toxicological investigations with several clinical and forensic applications including: workplace drug testing, drug treatment programs, drug-facilitated sexual assault (DFSA), drug compliance testing and drug abstinence monitoring, long-term drug exposure in living and in post-mortem cases. Hair is a particular matrix as no active drug metabolism or excretion occurs within its structure once drugs have been deposited, unless cosmetic treatments can partially degrade the incorporated drugs [1], [2].

This is not the only issue to be evaluated when interpreting hair analysis, but also the risk of passive exposure/contamination for the external presence of drugs in hair or the presence of endogenous compounds, which can also be exogenously administrated. In this latter case the sole presence of the substance in hair is insufficient to confirm exogenous administration [3], [4].

An important example of this latter occurrence is that of γ-hydroxybutyrate (GHB). GHB has a dual nature, endogenous and exogenous, which makes the proof of its eventual exogenous intake a complicated task. Indeed, trace amounts of GHB are produced in various tissues, including the brain, where it functions as both a precursor and a metabolite of the major inhibitory neurotransmitter γ-aminobutyric acid (GABA) [5]. On the other hand, GHB finds a broad application not only as a recreational drug of abuse in different contexts and in DFSA cases but also as a therapeutic agent under the form of sodium oxybate for the treatment of narcolepsy, the treatment of alcohol withdrawal syndrome and the maintenance of alcohol abstinence [6].

The aim of this paper was to provide a critical review of the literature to compare the results obtained in different studies regarding GHB endogenous levels in hair, taking into account the role of hair color, possible cosmetic treatment, age, gender and eventual pathologies which can interfere with GHB values in hair. The authors also focused on hair analysis in GHB chronic users, on analytical approaches adopted for the detection of single GHB doses in hair especially in DFSA cases and on the role of recently identified new metabolites of GHB, in particular GHB-glucuronide.

Lastly, an overview of analytical methods for the determination of GHB in hair together with the extraction techniques used and the possible applications of these methods was provided.

After examining all these aspects, the authors drew exhaustive conclusions and provided possible future perspectives in the toxicological investigation of GHB in hair. A practical protocol to be applied in suspected cases of GHB-FSA has been also proposed.

Materials and methods

The following databases (up to March 2017) PubMed, Scopus and Web of Science were used, searching the following key words: γ-hydroxybutyrate, GHB, GHB-glucuronide, hair. The main key words “GHB” and “γ-hydroxybutyrate” were searched singularly and then associated individually to each of the other keywords.

Of the 2304 sources found, only 20 [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26] were considered appropriate for the purpose of this paper. A flowchart of the selected papers and inclusion criteria are reported in Figure 1.

Figure 1: Flowchart of the selected papers and inclusion criteria.

Figure 1:

Flowchart of the selected papers and inclusion criteria.


GHB endogenous levels in hair

“As GHB is endogenous, GHB may be detected in hair at low concentration and as such, the presence of GHB alone is insufficient to confirm exogenous administration”. This sentence has been reported in the Guidelines of Society of Hair Testing 2012 [27], [28]. However, no reference values of endogenous GHB in hair were provided in the same guidelines.

Literature searching has identified eight different studies [8], [9], [15], [16], [18], [20], [21], [22] where endogenous GHB values were investigated in hair. The first study by Kintz and collaborators in 2003, analyzed 24 hair samples collected from 8 males and 16 females [8]. They tested the first proximal 3 cm (from the root) of each of the 24 hair samples obtaining a range of values from 0.5 to 12.0 ng/mg. Moreover, they also evaluated if hair color and gender could affect endogenous hair GHB values, but no significant differences were found among hair strands of various colors (black [n=10], mean: 2.37±0.68 ng/mg; brown [n=6], mean: 2.21±0.71 ng/mg; blond [n=8], mean: 2.44±0.39 ng/mg) or in subjects of different gender (males, mean: 2.21±0.57; females, mean: 2.47±0.69 ng/mg).

Similarly, in 2003, Goullè et al. [9] measured baseline levels of GHB in 61 drug-free donors with results in the range of 0.32–1.86 ng/mg. Also in this case, it was found that hair color did not affect GHB content (blond hair [n=12], 0.60±0.19 ng/mg GHB, brown hair [n=30], 0.90±0.42 ng/mg GHB, black hair [n=19], 0.90±0.37 ng/mg GHB). In the same study, segmental hair analysis into 3 mm segments was performed in the other 12 volunteers (non-GHB consumers). In this case, a mean concentration of 1.22 ng/mg (range: 0.31–8.4 ng/mg) and a relative standard deviation for each individual ranging from 6.75% to 37.98%, was detected.

After these early investigations, recently further studies have been published in this field. Schröck et al. [15], obtained endogenous hair GHB in the range of 0.1–1.3 ng/mg examining hair samples of 27 GHB-free subjects with 8 of the 27 with concentrations below the limit of quantitation (LOQ) of 0.1 ng/mg hair.

In 2015, Bertol and Busardò and their respective research groups performed a study where hair samples of 30 volunteers were selected and divided according to color (10 samples of black hair, 10 samples of blond hair, and 10 samples of hair dyed with different colors) for the determination of endogenous GHB [16]. GHB was detected in the range between 0 and 5.09 ng/mg. In detail, black hair mean concentration was 2.11±1.40 ng/mg with a range from<limit of detection (LOD) to 4.49 ng/mg; the blond hair mean concentration was 2.25±1.31 ng/mg with a range from 0.58 to 5.09 ng/mg and the dyed hair mean concentration was 2.39±0.97 ng/mg with a range from 0.61 to 4.02 ng/mg. Similarly to the studies of Kintz et al. [8] and Goullè et al. [9] there were no statistically significant differences in GHB concentration among the different hair colors. Moreover, no significant differences with respect to sex or age of the subjects were found.

In the same year, Bertol et al. [16] reported that, due to sweat contamination, GHB concentration in the first 0.5 cm hair segment of a group of non-consumers was statistically higher in comparison to all the other subsequent segments where mean GHB concentration was 1.27±0.73 ng/mg.

More recently, Vaiano and colleagues [18] published another study where they investigated the role of age and gender on GHB baseline levels in hair and for this purpose a large number of subjects were included (n=150). GHB was detected in the range of 0.27–2.84 ng/mg (mean: 0.71±0.289 ng/mg), in accordance with previously published range values [8], [9], [15], [16]. Moreover, the authors highlighted that in males hair GHB concentration was significantly higher than in females: 0.829 vs. 0.596 ng/mg; p<0.05.

This result was in contrast with their previous study, where it was not highlighted. Nevertheless, in this case a higher number of subjects was employed and the first cm of each hair sample was excluded to reduce the risk of sweat contamination as far as possible. Similarly to the results obtained by Vaiano et al., a significant difference (p<0.001) between males and females was also detected by Shi et al. [20] when analyzing endogenous GHB in hair samples of 66 drug-free Chinese donors. The mean GHB value in males was 2.95 ng/mg (0.92–4.91 ng/mg, n=35), whereas the mean value in females was 0.77 ng/mg (0.28–1.95 ng/mg, n=31).

To demonstrate that endogenous GHB values in hair are not affected by post mortem enzymatic processes, Castro et al. [21] evaluated whole blood and hair post-mortem GHB values in 32 fatalities with previous information on death and autopsy data. Post-mortem interval (up to 5 days between death and sampling) affected GHB whole blood concentrations, but not that in hair samples where GHB was in a range of values similar to those of ante-mortem cases: 0.16–3.12 ng/mg (mean: 0.92 ng/mg).

Finally, in 2016 Kintz [22] documented a case of single exposure to GHB with a novel approach and he also collected hair samples from 12 non-consumers as a control group. The not decontaminated hair was cut into 6×1 cm segments. In the first cm, GHB values were in the range of 0.2–20 ng/mg, whereas in all the other segments it was always lower than 4 ng/mg.

All the above reported studies are briefly summarized in Table 1.

Table 1:

Brief overview of studies focusing on endogenous GHB concentrations in hair.

Hair colorGenderNGHB conc., ng/mgFurther informationStudy/year/reference
Black, brown and blond8 M+16 F240.5–12aFirst 3 cmKintz et al. [8]
Black, brown and blondM+F610.32–1.86aNo hair segmentationGoullè et al. [9]

Hair segmentation (3 mm)
N.S.N.S.270.1–1.3a,eSchröck et al. [15]
N.S.N.S.300.0–5.09aHair segmentation (5 mm)Bertol et al. [16]
Black5 M+5 F100–4.49a

Blond5 M+5 F100.58–5.09a


Various colors6 M+6 F121.27±0.73bHair segmentation (5 mm) – The first 5 mm were excluded
Various colors75 M+75 F1500.71±0.29b

The first cm was excludedVaiano et al. [18]
N.S.35 M+31 F660.28–4.91a

The first 3 cm were analyzedShi et al. [20]


N.S.23 M+9 F320.16–3.12a

Post-mortem casesCastro et al. [21]
N.S.N.S.12First cm: 0.2–20a

Other segments: <4
Hair samples were cut into 1 cm segments. Hair samples were not decontaminatedKintz [22]

  1. aRange. bMean±SD. cMean. dMedian. N.S., not specified. eIn eight of the 27 hair samples the GHB concentrations were below the LOQ of 0.1 ng/mg hair.

GHB long-term exposure in hair

There are few reports in the literature where chronic GHB exposure has been documented using hair. In 2005, a first French case of a fatal GHB overdose involving a 43-year-old man was studied by Kintz et al. [10] measuring GHB at very high concentrations in femoral and cardiac blood, urine, bile, vitreous humor, gastric content and pubic hair, as no head hair was available. Pubic hair was cut into three segments of 8 mm each and GHB was detected at the following concentrations: 25, 22.6 and 19.4 ng/mg, indicating a chronic GHB abuse.

In 2012 Bertol et al. [14] presented a case involving a 40-year-old man with a long history of GHB abuse and abstinence in the previous 2 months due to house arrest. A 17 cm long hair shaft was taken from the posterior vertex of the head and cut into 1 cm segments for the first 3 cm and then into 2 cm segments for the remaining proximal 14 cm. Ten different segments were obtained in total. The first three showed the following concentrations: 3.52, 1.49 and 1.2 ng/mg, whereas in the distal seven segments, GHB concentration ranged from 4.74 to 10.74 ng/mg. These GHB values allowed the authors to confirm that during the period in which the subject was under house arrest he did not use GHB whereas previously he was a chronic consumer and that the first hair segment showed higher GHB values for drug incorporation through sweat.

Mehling et al. [19] reported a DFSA case involving a 6-year-old female, who died following GHB sedation. GHB analysis was performed on a 16 cm hair shaft. The first proximal 4 cm of the hair were cut into 2 cm segments, whereas the next 12 cm were cut into segments of 1 cm length. The highest concentrations of GHB in the range of 13.6–40.8 ng/mg were found in the proximal seven hair segments and allowed to demonstrate a long exposure to GHB. When confronted with these results, the girl’s uncle admitted the chronic administration of GHB to the child in the previous 8 months before death.

In the case of a 69-year-old man who was discovered dead at a friend’s home, Jamey et al. reported a value of hair GHB in a 6 cm segment of 96.3 ng/mg suggesting a repeated consumption of this substance [23]. Toxicological analysis in peripheral blood also revealed the presence of 3-mmethylmethcathinone, pseudoephedrine together with GHB.

GHB single dose detected in hair

The identification of GHB exposure following a single dose administration has always represented a very difficult task for all forensic toxicologists dealing with this issue. As GHB has a very short detection window in conventional biological matrices, about 4–5 h in blood and 8–10 h in urine, if a longer time has elapsed after its ingestion there is little hope of detecting measurable amounts in these two matrices [5], [27]. Hence, some studies have focused on the detection of a single GHB dose in hair, which represents a crucial point especially in DFSA and other criminal cases [7], [8], [9], [15], [16], [20], [22].

One of the first studies [7] published in 2001 investigating GHB in hair, following a single dose administration, involved a 22-year-old female who had ingested a single GHB dose and died about 7 h later. Hair was plucked from the scalp. The root bulbs were removed, washed with sodium dodecyl sulfate and water and analyzed, whereas the hair shaft, also washed with sodium dodecyl sulfate and water, was cut in segments of 1.3 cm (0.5 inch). Segmental hair analysis showed no detectable amounts of GHB (LOD=1 ng/mg), whereas hair root bulbs showed the following concentrations: 47.4 ng/mg for washed and 2221 ng/mg for unwashed hair, demonstrating that GHB is rapidly distributed into the hair follicle.

In a study published in 2003, Kintz et al. sought to investigate GHB hair concentration after a single intake [8]. For this reason, they administered a 25 mg/kg single dose of GHB to a 41-year-old man (weight 67 kg) and had available a DFSA case involving a 19-year-old female who had drunk a soft drink spiked with the drug. In both cases hair was collected 1 month after the single exposure. Hair samples were cut into 3-mm segments over a length of 3 cm (10 segments). Segmental hair analysis revealed in both cases GHB peak values, in the fifth segment for the administered subject and in the fourth segment in the DFSA case. The GHB peak values detected in the fifth and fourth segments demonstrated that a single exposure could be detected in hair (Figure 2 A and B).

Figure 2: Cases of single GHB detection in hair from international literature.In all cases (A–I) a segmental hair analysis to determine the “targeted segment” was performed.

Figure 2:

Cases of single GHB detection in hair from international literature.

In all cases (A–I) a segmental hair analysis to determine the “targeted segment” was performed.

Goullè et al. [9] reported a case regarding a 29-year-old Black female raped under the influence of GHB, after drinking a glass of champagne. A 24-cm black hair shaft was collected and cut into 3-mm long segments (80 segments in total) 7 days after the rape and analyzed for GHB. The first three segments closer to the scalp showed the following GHB concentrations: 3.1, 5.3 and 4.3 ng/mg, whereas in the other 77 segments the mean concentration was 0.71 ng/mg (SD=0.17 ng/mg). This mean value represented the baseline GHB level of the woman, whereas the highest GHB concentration detected in the second proximal segment was suggestive of an exogenous GHB administration even taking into account the possible contamination by sweat.

In contrast to the results of these two previous studies [8], [9] where a single GHB dose could have be identified in hair, Schröck et al. [15] found no increase in hair GHB after administering a single dose of 1.5 mL γ-butyrolactone (corresponding to 2.1 g of GHB, assuming a complete conversion). Head hair from to two volunteers was collected on days 9, 14, 25, and 28 for one case and on days 8, 17, 25, 37 for the other case. In both cases, head hair were segmented into 7 mm fragments. In addition, beard hair of 1 mm length was collected every day. GHB concentrations in head hair were in the range of 0.1–0.6 ng GHB per mg hair. In beard hair, the measured GHB concentrations were up to 20 times higher than those in head hair falling into the range of 0.2–3.1 ng/mg and 0.7–3.5 ng/mg, respectively, but no increased GHB values were observed for the first days after the intake of GBL. The explanation for these variations of GHB content in beard hair, provided by the authors, was a possible external contamination by sweat.

In all the above reported cases, what allowed the authors to confirm the administration of a single GHB dose in hair was the eventual rise of GHB content in targeted hair segments in comparison to the content in the others. However, none of these studies reported which had to be the degree of rise in hair concentration of GHB. Neither the Guidelines of Society of Hair Testing reported in 2012 the degree of this elevation [28]. They only stated that it had be “consistent with the approximate timeframe of the incident” in order to differentiate between endogenous and exogenous GHB.

In the Guidelines for the Forensic Analysis of Drugs Facilitating Sexual Assault and Other Criminal Acts [29], the United Nations Office on Drugs and Crime (UNODC) recommends that “the strand of hair has to be cut in 5–10 small segments (0.3–0.5 cm long) and each segment analyzed for GHB to identify if one segment has GHB concentration 10 times higher than the others, suggesting in this way possible administration of exogenous GHB”. Four years after the release of this document, Bertol et al. [16] proposed lower ratios for GHB concentration in targeted segment vs. the others. The authors orally administered to 12 subjects a single 25 mg/kg GHB dose and hair shafts were taken 1 month and 2 months later and cut into 0.5 cm segments. Two ratios were obtained: 4.45:1 (95% CI 3.52–5.63) for GHB in the second segment in the hair samples collected after 1 month vs. the others and 3.35:1 (95% CI 2.14–5.18) for the fourth segment in the hair samples collected after 2 months vs. the others (Figure 2C and D), recommended for a positive identification of single GHB intake.

Indeed, Bertol et al. applied these two ratios to three DFSA cases, allowing the identification of a single exposure in two cases (cases 1 and 2) (Figure 2E and F) whereas for the third case it was not possible to draw exhaustive conclusions [16] (Figure 2G).

The two ratios proposed by Bertol et al. [16] were obtained from hair samples collected 1 and 2 months after a single GHB exposure, but after this time frame no information was available about eventual GHB concentration detectable in hair following a single dose when a longer period of time elapsed from drug intake. In this regard, Busardò et al. [25] monitored GHB peak concentration in a targeted hair segment after a single DFSA administration over a period of 12 months. The same authors also calculated month by month the ratios between GHB value in targeted segments and that in the others for up to 12 months, showing a progressive decrease from 5.56 at the 1st month to 2.84 at the 12th month [25] (Figure 2I).

The month-by-month decrease of this ratio can be explained by the decay of hair GHB concentration, which occurred during the 12-month timeframe up to 51.6% at the 12th month. Moreover, differently from other drugs of abuse no significant GHB migration in the hair shaft was found.

Differently from the previous study, Shi et al. [20] reported another DFSA case involving a 20-year-old female where a 6 cm hair sample was collected 1 month after the assault and segmented into 1 cm fragments. High GHB concentration was found in the second segment (4.31 ng/mg) suggesting a GHB exogenous administration. However, no ratio with GHB values in the other segments was provided, making any definitive conclusion difficult (Figure 2H).

Different from all the above reported studies, is the approach to document a single GHB dose in hair, published by Kintz in 2016 [22], where two different cases were evaluated. The first was that of a subject administered a GHB dose of 25 mg/kg whose hair was collected 12 h after dosing and a 22-year-old female, a victim of a sexual assault, whose hair was collected 14 h after the assault. In both cases, hair samples were not decontaminated and cut into 6×1 cm segments. In the first cm the following concentrations were found: 1040 and 850 ng/mg, respectively, whereas in the remaining segments GHB concentration was always lower than 20 ng/mg. The comparison of the GHB values detected in the first hair segment of these two individuals with the ones of a control group of 12 subjects, in the range of 0.2–20 ng GHB per mg hair allowed Kintz to easily discriminate between endogenous and exogenous GHB. This new approach which is based on the analysis of proximal hair samples non decontaminated from eventual sweat contribution allowed Kintz to obtain a much better discriminating ratio which could be used in routine cases, considering that the risk of GHB passive contamination is limited because the drug is generally used in liquid formulation and not smoked [22].

GHB-glucuronide and other potential metabolites in hair

In 2003 Petersen et al. identified a new GHB metabolite in urine: GHB-glucuronide (GHB-glucuronide), with the hypothesis of using this metabolite as a biomarker for GHB intoxication, by analogy with ethyl glucuronide as a biomarker of ethanol consumption. However, the results obtained in this first study did not look promising [30]. Only a few reports investigating GHB-glucuronide in different matrices [24], [26], [31], [32], were published after this study, two of which focused on hair [24], [26], Wang et al. [24] investigated the presence of GHB-glucuronide in the hair of 10 control subjects (laboratory staff) and in two GHB abusers. In the control group, GHB-glucuronide was found in the range of<LOQ (0.48 ng/mg) to 1.2 ng/mg, whereas in the two GHB users, GHB-glucuronide was only slightly elevated in 10 different 3 mm hair segments in one of the subjects (range 1.7–3.1 ng/mg) and below the LOQ in the other.

Busardò et al. [26] investigated one 10 cm head hair sample, from a 45-year-old man who had undergone sodium oxybate treatment for 6 months. After decontamination, the hair sample was dried and cut into 10 segments of 1 cm each and analyzed for GHB, GHB-glucuronide, GBL and GABA by UHPLC-MS/MS. The latter two compounds were not detected, whereas GHB was found in the first six proximal segments at significantly higher concentrations compared to the ones measured in last four segments, GHB-glucuronide was detected in all segments in the range: of 0.32–0.83 ng/mg, but no significant variation was found among the all.

In 2015 Hanisch et al. [33] investigated sulfonated metabolite of GHB (GHB-SUL) in urine samples on the reasonable assumption that it could be formed. The obtained results evidenced traces of GHB-SUL in urine, therefore indicating that GHB is not only glucuronidated but also sulfonated. To our knowledge no studies investigating GHB-SUL have been performed in hair so far.

Analytical methods for GHB analysis in hair

Several analytical methods have been published for GHB analysis in hair [7], [8], [9], [12], [13], [14], [15], [16], [17], [18], [20], [24], [26], using different techniques: GC-MS [7], [14], [18], GC-MS/MS [8], [9], [13], [20], LC-MS/MS [12], [14], [15], [16], [17] and UHPLC-MS/MS [24], [26]. The majority of these methods included only quali-quantitaive determination of GHB. Some others detected GHB with other compounds, such as ethyl-glucuronide [13], GABA, GBL [24] and GHB-glucuronide [24], [26].

Table 2 reports a brief overview of analytical methods applied for qualitative and quantitative analysis of GHB and metabolites in hair.

Table 2:

Analytical methods applied for quali-quantitative analysis of GHB and metabolites in hair.

Sample weight, mgSample preparationAnalytical techniqueLOD, ng/mgLOQ, ng/mgLinearity, ng/mgOther analytesStudy/year/reference
10Washing (1×5 mL 1% sodium dodecyl sulfate, 5×5 mL deionized water, 3 mL of methanol), water bath under alkaline conditions at 40°C for 2 h, SPE, derivatizationGC-MS1NANAKalasinsky et al. [7]
5–10Washing (2×5 mL methylene chloride), cut, overnight incubation in 0.1 N NaOH, neutralization, LLE under acidic conditions, evaporation, derivatizationGC-MS/MS0.10.20.2–20Kintz et al. [8]
5Washing (1×methanol, 2×hot water, 2×methylene chloride), cut, digestion under alkaline conditions, neutralization, LLE under acidic conditions, evaporation, derivatizationGC-MS/MSNANANAGoulle et al. [9]
25Washing (acetone), digestion under alkaline conditions, neutralization, LLE, evaporation, reconstitution in mobile phaseLC-MS/MS0.20.40.2–100Stout et al. [12]
20Cut, washing (methanol), overnight sonication in water, SPE, evaporation, derivatizationGC-MS/MSNANANAEtGPaul et al. [13]
25For GC–MS analysis:

Washing (2×5 mL methylene chloride), cut, overnight incubation with NaOH, neutralization, LLE under acidic conditions, derivatization

For LC-MS/MS analysis:

Washing (2×5 mL methylene chloride), cut, rapid digestion with NaOH, LLE under acidic conditions, evaporation, reconstitution in mobile phase

GC–MS: 0.4

LC-MS/MS: 0.5
GC–MS: 0.6

LC-MS/MS: 0.6
GC–MS: 1–50

LC-MS/MS: 0.6–50
Bertol et al. [14]
20Washing (water, acetone and methylene chloride), cut, ultrasonic bath in water, evaporation, reconstitution in 99:1 water: acetonitrile with 0.1% formic acidLC-MS/MSNA0.10.1–10Schröck et al. [15]
25Washing (2×5 mL methylene chloride), digestion under alkaline conditions, LLE under acidic conditions, evaporation, reconstitution in mobile phaseLC-MS/MS0.30.50.5–30.0Bertol et al. [16]
25Washing (1×methanol, 1×methylene chloride, 1×methanol), pulverization, digestion under alkaline conditions, neutralization, LLE, SPE, evaporation, reconstitution in mobile phase, filtrationLC-MS/MS0.331.20.4–50Jagerdeo et al. [17]
25Washing (2×5 mL methylene chloride), cut, overnight incubation with NaOH, LLE under acidic conditions, derivatizationGC-MS0.050.19NAVaiano et al. [18]
20Washing (deionized water and acetone), cut, digestion under alkaline conditions, neutralization, LLE under acidic conditions, derivatizationGC/MS/MS0.020.050.05–15Shi et al. [20]
10Washing (1×1 mL isopropanol, 2×0.5 mL water), pulverization, incubation under acidic conditions, filtration, evaporation, reconstitution in deionized water, centrifugationUHPLC/MS/MSNA0.32 for GHB

(0.48 for GHB glucuronide)
LOQ 0.32–50GHB glucuronideWang et al. [24]
25Washing (2×2 mL methylene chloride), cut, incubation in M3 buffer, dilution with waterUHPLC/MS/MS0.2 for GHB

(0.2 for GHB glucuronide)
0.5 for GHB

(0.5 for GHB glucuronide)
0.5–100GHB glucuronide


Busardò et al. [26]

  1. NA, not available; EtG, ethyl-glucuronide.

Conclusions and future perspectives

This comprehensive review allowed outlining some useful considerations:

  • Summing up all the studies investigating endogenous GHB in hair [7], [8], [9], [15], [16], [20], [22] a very broad concentration range can be reported: 0–12 ng/mg. Moreover, considering the experiment carried out by Kintz [22] in non-decontaminated hair samples, the upper limit of this range reaches 20 ng/mg. Therefore, the high variability of GHB concentration in hair does not allow the proposal of a reliable GHB cut-off which can be applied unanimously to all cases to significantly discriminate between endogenous and exogenous GHB.

  • The majority of studies have detected higher GHB values in the hair segment closest to the scalp, demonstrating the contribution from sweat even when hair was correctly decontaminated. In the light of this occurrence, at least the first 5 mm hair shaft should be excluded from analysis to avoid erroneous conclusions.

  • All the studies investigating the detection of a single GHB dose in hair, except the one of Kintz [22] where a different approach is presented, indicate that it is necessary to wait a reasonable length of time for collecting hair (from a minimum of 7 days up to 1 month or more). The interval of 1 month from the possible exposure was mainly suggested to collect hair and this is the interval of time we recommend. The segmental analysis of hair into 3 or 5 mm segments and the calculation of a ratio between the targeted segment and the others represent a reliable method to detect single GHB dose in hair and the ratios proposed by Bertol et al. [16] for hair samples collected after 1 and 2 months can be applied in routine cases.

  • Presently, the only approach which may allow to demonstrate a GHB ingestion shortly after the exposure is the one of Kintz [22], but it can be applied only if the subject has not washed his/her hair because it is based on the contamination property of sweat.

  • The only two studies [24], [26] so far performed, investigating GHB-glucuronide in hair, highlighted that this metabolite does not seem to provide any diagnostic information regarding GHB exposure.

Finally, taking into consideration all the studies up to here discussed we wish to propose a practical protocol to be applied in all suspected cases of GHB-FSA, which is presented in Figure 3.

Figure 3: Practical protocol to be applied in all suspected cases of GHB-FSA.

Figure 3:

Practical protocol to be applied in all suspected cases of GHB-FSA.

Corresponding author: Dr. Simona Pichini, PhD, National Centre on Addiction and Doping, Istituto Superiore di Sanitá, Rome, Italy, Phone: +39 0649906545


The authors thank Michele Sciotti for technical assistance in manuscript preparation.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Kintz P, Villain M, Cirimele V. Hair analysis for drug detection. Ther Drug Monit 2006;28:442–6.10.1097/01.ftd.0000211811.27558.b5Search in Google Scholar PubMed

2. Kintz P, Salomone A, Vincenti M. Hair analysis in clinical and forensic toxicology, 1st ed. Tokyo: Academic Press, 2015.Search in Google Scholar

3. Gautam L., Cole MD. hair analysis in forensic toxicology. Available at: Accessed: 2 Jan 2017.Search in Google Scholar

4. Busardò FP. The importance of hair testing in GHB facilitated sexual assault cases. J Forensic Leg Med 2016;39:74–5.10.1016/j.jflm.2016.01.020Search in Google Scholar PubMed

5. Busardò FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol 2015;13:47–70.10.2174/1570159X13666141210215423Search in Google Scholar PubMed PubMed Central

6. Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. Eur Rev Med Pharmacol Sci 2015;19:4654–63.Search in Google Scholar

7. Kalasinsky KS, Dixon MM, Schmunk GA, Kish, SJ. Blood, brain, and hair GHB concentrations following fatal ingestion. J Forensic Sci 2001;46:728–30.10.1520/JFS15032JSearch in Google Scholar

8. Kintz P, Cirimele V, Jamey C, Ludes B. Testing for GHB in hair by GC/MS/MS after a single exposure. Application to document sexual assault. J Forensic Sci 2003;48:195–200.10.1520/JFS2002209Search in Google Scholar

9. Goullé JP, Chèze M, Pépin G. Determination of endogenous levels of GHB in human hair. Are there possibilities for the identification of GHB administration through hair analysis in cases of drug-facilitated sexual assault? J Anal Toxicol 2003;27:574–80.10.1093/jat/27.8.574Search in Google Scholar PubMed

10. Kintz P, Villain M, Pélissier AL, Cirimele V, Leonetti G. Unusually high concentrations in a fatal GHB case. J Anal Toxicol 2005;29:582–5.10.1093/jat/29.6.582Search in Google Scholar PubMed

11. Rossi R, Lancia M, Gambelunghe C, Oliva A, Fucci N. Identification of GHB and morphine in hair in a case of drug-facilitated sexual assault. Forensic Sci Int 2009;186:e9–e11.10.1016/j.forsciint.2009.01.017Search in Google Scholar PubMed

12. Stout PA, Simons D, Kerrigan S. Quantitative analysis of gamma-hydroxybutyrate at endogenous concentrations in hair using liquid chromatography tandem mass spectrometry. J Forensic Sci 2010;55:531–7.10.1111/j.1556-4029.2009.01304.xSearch in Google Scholar PubMed

13. Paul R, Tsanaclis L, Kingston R, Berry A, Guwy A. Simultaneous determination of GHB and EtG in hair using GCMS/MS. Drug Test Anal 2011;3:201–5.10.1002/dta.172Search in Google Scholar PubMed

14. Bertol E, Argo A, Procaccianti P, Vaiano F, Di Milia MG, Furlanetto S, et al. Detection of gamma-hydroxybutyrate in hair: validation of GC-MS and LC-MS/MS methods and application to a real case. J Pharm Biomed Anal 2012;70:518–22.10.1016/j.jpba.2012.07.009Search in Google Scholar PubMed

15. Schröck A, Hari Y, König S, Auwärter V, Schürch S, Weinmann W. Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL – an experiment with two volunteers. Drug Test Anal 2014;6:363–6.10.1002/dta.1498Search in Google Scholar PubMed

16. Bertol E, Mari F, Vaiano F, Romano G, Zaami S, Baglìo G, et al. Determination of GHB in human hair by HPLC-MS/MS: development and validation of a method and application to a study group and three possible single exposure cases. Drug Test Anal 2015;7:376–84.10.1002/dta.1679Search in Google Scholar PubMed

17. Jagerdeo E, Montgomery MA, LeBeau MA. An improved method for the analysis of GHB in human hair by liquid chromatography tandem mass spectrometry. J Anal Toxicol 2015;39:83–8.10.1093/jat/bku130Search in Google Scholar PubMed

18. Vaiano F, Serpelloni G, Furlanetto S, Palumbo D, Mari F, Fioravanti A, et al. Determination of endogenous concentration of γ-hydroxybutyric acid (GHB) in hair through an ad hoc GC-MS analysis: a study on a wide population and influence of gender and age. J Pharm Biomed Anal 2016;118:161–6.10.1016/j.jpba.2015.10.036Search in Google Scholar PubMed

19. Mehling LM, Johansen SS, Wang X, Doberentz E, Madea B, Hess C. Drug facilitated sexual assault with lethal outcome: GHB intoxication in a six-year-old girl. Forensic Sci Int 2016;259:25–31.10.1016/j.forsciint.2015.12.044Search in Google Scholar PubMed

20. Shi Y, Cui X, Shen M, Xiang P. Quantitative analysis of the endogenous GHB level in the hair of the Chinese population using GC/MS/MS. J Forensic Leg Med 2016;39:10–5.10.1016/j.jflm.2016.01.002Search in Google Scholar PubMed

21. Castro AL, Tarelho S, Dias M, Reis F, Teixeira, HM. Comparison of endogenous GHB concentrations in blood and hair in death cases with emphasis on the post mortem interval. Int J Legal Med 2016;130:959–65.10.1007/s00414-016-1321-8Search in Google Scholar PubMed

22. Kintz P. A novel approach to document single exposure to ghb: hair analysis after sweat contamination. J Anal Toxicol 2016;40:563–4.10.1093/jat/bkw052Search in Google Scholar PubMed

23. Jamey C, Kintz P, Martrille L, Raul JS. Fatal combination with 3-methylmethcathinone (3-MMC) and gamma-hydroxybutyric acid (GHB). J Anal Toxicol 2016;40:546–52.10.1093/jat/bkw058Search in Google Scholar PubMed

24. Wang X, Linnet K, Johansen S. Development of a UPLC-MS/MS method for determining γ-hydroxybutyric acid (GHB) and GHB glucuronide concentrations in hair and application to forensic cases. Forensic Toxicol 2016;34:51–60.10.1007/s11419-015-0285-6Search in Google Scholar

25. Busardò FP, Vaiano F, Mannocchi G, Bertol E, Zaami S, Marinelli E. Twelve months monitoring of hair GHB decay following a single dose administration in a case of facilitated sexual assault. Drug Test Anal 2017;9:953–6.10.1002/dta.2100Search in Google Scholar PubMed

26. Busardò FP, Kyriakou C, Marchei E, Pacifici R, Pedersen DS, Pichini S. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursors and metabolites in different specimens: application to clinical and forensic cases. J Pharm Biomed Anal 2017;137:123–31.10.1016/j.jpba.2017.01.022Search in Google Scholar PubMed

27. Busardo FP, Kyriakou C. GHB in biological specimens: which cut-off levels should be taken into consideration in forensic toxicological investigation? Recent Pat Biotechnol 2014;8:206–14.10.2174/1872208309666150504143155Search in Google Scholar PubMed

28. Cooper GA, Kronstrand R, Kintz P. Society of hair testing. Society of hair testing guidelines for drug testing in hair. Forensic Sci Int 2012;218:20–4.10.1016/j.forsciint.2011.10.024Search in Google Scholar PubMed

29. The United Nations Office on Drugs and Crime (UNODC). Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts United Nations. New York, 2011.Search in Google Scholar

30. Petersen IN, Tortzen C, Kristensen JL, Pedersen DS, Breindahl T. Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide. J Anal Toxicol 2013;37:291–7.10.1093/jat/bkt027Search in Google Scholar PubMed

31. Nymann Petersen I, Langgaard Kristensen J, Tortzen C, Breindahl T, Sejer Pedersen D. Synthesis and stability study of a new major metabolite of γ-hydroxybutyric acid. Beilstein J Org Chem 2013;9:641–6.10.3762/bjoc.9.72Search in Google Scholar PubMed PubMed Central

32. Tittarelli R, Pichini S, Pedersen DS, Pacifici R, Moresco M, Pizza F, et al. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment. Forensic Sci Int 2017;274:70–4.10.1016/j.forsciint.2017.01.015Search in Google Scholar PubMed

33. Hanisch S, Stachel N, Skopp G. A potential new metabolite of gamma-hydroxybutyrate: sulfonated gamma-hydroxybutyric acid. Int J Legal Med 2016;130:411–4.10.1007/s00414-015-1235-xSearch in Google Scholar PubMed

Received: 2017-05-08
Accepted: 2017-06-19
Published Online: 2017-08-01
Published in Print: 2018-01-26

©2018 Walter de Gruyter GmbH, Berlin/Boston